With the aim to identify novel somatic events involved in the progression of prostate cancer (PCa), Berger et al. sequenced PCa samples and found genetic rearrangements disrupting both PTEN and MAGI2. These rearrangements included two independent inversions and two long-range intrachromosomal inversions [115]. This evidence concerns the gene MAGI2 and prostate carcinoma.